OLIG2 (Oligodendrocyte transcription factor 2) is a Class B/E basic helix-loop-helix (bHLH) transcription factor that functions as a master regulator of oligodendrocyte and motor neuron lineage specification in the central nervous system. OLIG2 binds E-box DNA motifs (CANNTG) as homo- or heterodimers with other bHLH proteins, regulating transcription of genes essential for neural cell fate determination. The protein is induced by Sonic hedgehog (Shh) signaling and cooperates with transcription factors NKX2-2, OLIG1, SOX10, and ASCL1 to establish the pMN (motor neuron progenitor) domain of the ventral neural tube, promoting oligodendrocyte precursor cell (OPC) specification and oligodendrocyte differentiation while antagonizing V2/V3 interneuron fates. OLIG2 also functions in cell cycle regulation by repressing p21 and antagonizing p53 acetylation. The protein localizes primarily to the nucleus where it associates with chromatin, though cytoplasmic localization can occur when the nuclear localization signal in the bHLH domain is masked. OLIG2 is a diagnostic marker for diffuse gliomas, where it maintains OPC-like/proneural tumor states.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific | IBA GO_REF:0000033 | ACCEPT | Summary: OLIG2 is a well-established bHLH transcription factor that regulates gene expression during neural development. UniProt confirms OLIG2 is "required for oligodendrocyte and motor neuron specification" and functions as a transcriptional regulator. The bHLH domain (residues 108-162) is essential for DNA binding. This is a core function of OLIG2. Reason: OLIG2 is definitively a DNA-binding transcription factor. The bHLH domain is well-characterized and the protein functions to regulate transcription of genes involved in oligodendrocyte and motor neuron specification. This IBA annotation accurately reflects the core molecular function. Supporting Evidence: UniProtKB:Q13516 Required for oligodendrocyte and motor neuron specification in the spinal cord UniProtKB:Q13516 Class B basic helix-loop-helix protein 1 |
| GO:0005634 nucleus | IBA GO_REF:0000033 | ACCEPT | Summary: OLIG2 is primarily a nuclear protein as expected for a transcription factor. UniProt indicates nucleus as the primary subcellular location with evidence from PROSITE-ProRule:PRU00981. Reason: As a transcription factor, OLIG2 must localize to the nucleus to perform its function. UniProt confirms nuclear localization. The bHLH domain contains a nuclear localization signal that may be masked in the native form until interaction with partner proteins. Supporting Evidence: UniProtKB:Q13516 SUBCELLULAR LOCATION: Nucleus UniProtKB:Q13516 The NLS contained in the bHLH domain could be masked in the native form |
| GO:0007423 sensory organ development | IBA GO_REF:0000033 | REMOVE | Summary: OLIG2 is specifically involved in oligodendrocyte and motor neuron specification in the CNS (brain and spinal cord). There is no evidence that OLIG2 functions in sensory organ (eye, ear, nose) development. This IBA annotation appears to be an over-propagation from other bHLH family members that do function in sensory organs. Reason: OLIG2's documented functions are restricted to oligodendrocyte differentiation and motor neuron specification in the neural tube and CNS. UniProt describes its function as "Required for oligodendrocyte and motor neuron specification in the spinal cord, as well as for the development of somatic motor neurons in the hindbrain." There is no mention of sensory organ development. The IBA propagation from other bHLH family members is inappropriate here as OLIG2 has specialized neural tube functions distinct from sensory organ development. This is likely phylogenetic over-propagation from other family members like ATOH1 or NEUROD1 which do function in sensory development. Supporting Evidence: UniProtKB:Q13516 Required for oligodendrocyte and motor neuron specification in the spinal cord, as well as for the development of somatic motor neurons in the hindbrain |
| GO:0070888 E-box binding | IBA GO_REF:0000033 | ACCEPT | Summary: bHLH transcription factors characteristically bind E-box sequences (CANNTG). OLIG2 contains a canonical bHLH domain and is expected to bind E-box motifs. The SELEX study (PMID:28473536) systematically analyzed DNA binding of human transcription factors including bHLH proteins. Reason: E-box binding is the canonical DNA binding specificity for bHLH transcription factors. OLIG2's bHLH domain (residues 108-162) is well-conserved and the protein belongs to the class B bHLH family. This is a core molecular function. Supporting Evidence: UniProtKB:Q13516 Class B basic helix-loop-helix protein 1 PMID:28473536 systematic analysis of DNA binding specificities of full-length TFs |
| GO:0045944 positive regulation of transcription by RNA polymerase II | IBA GO_REF:0000033 | ACCEPT | Summary: OLIG2 functions as a transcription factor that promotes oligodendrocyte and motor neuron gene expression programs. It cooperates with other factors like ZNF488 to activate transcription of oligodendrocyte differentiation genes. Reason: OLIG2 is documented to promote oligodendrocyte differentiation by activating target genes. UniProt states it "Functions together with ZNF488 to promote oligodendrocyte differentiation." This positive transcriptional regulation is a core function. Supporting Evidence: UniProtKB:Q13516 Functions together with ZNF488 to promote oligodendrocyte differentiation |
| GO:0061564 axon development | IBA GO_REF:0000033 | KEEP AS NON CORE | Summary: OLIG2's primary functions are in oligodendrocyte and motor neuron cell fate specification. While oligodendrocytes myelinate axons, OLIG2 itself does not directly regulate axon development processes. Motor neurons do extend axons, but OLIG2's role is in specifying motor neuron identity, not in axon growth or guidance per se. Reason: Axon development is an indirect downstream consequence of OLIG2's role in motor neuron specification. OLIG2 specifies motor neuron identity; the resulting motor neurons then extend axons. However, OLIG2 is not known to directly regulate axon development genes or processes. This is a secondary effect rather than a core function. The annotation is not wrong but represents a downstream phenotypic effect. Supporting Evidence: UniProtKB:Q13516 Required for oligodendrocyte and motor neuron specification in the spinal cord |
| GO:0003677 DNA binding | IEA GO_REF:0000043 | ACCEPT | Summary: OLIG2 contains a bHLH domain that mediates DNA binding. This is a more general term than the more specific annotations for E-box binding and transcription factor activity. Reason: This is a valid general annotation. OLIG2's bHLH domain binds DNA. While more specific terms like E-box binding (GO:0070888) are also present, keeping this general annotation provides appropriate coverage. The IEA from UniProt keyword mapping is appropriate. Supporting Evidence: UniProtKB:Q13516 Class B basic helix-loop-helix protein 1 |
| GO:0003700 DNA-binding transcription factor activity | IEA GO_REF:0000120 | ACCEPT | Summary: This is the parent term of GO:0000981 (RNA polymerase II-specific). OLIG2 is clearly a DNA-binding transcription factor. Reason: Valid but more general than GO:0000981 which is also annotated. Both annotations are acceptable - the IEA provides a broader term while the IBA provides the more specific Pol II-specific term. Supporting Evidence: UniProtKB:Q13516 Required for oligodendrocyte and motor neuron specification |
| GO:0005634 nucleus | IEA GO_REF:0000120 | ACCEPT | Summary: Duplicate of the IBA annotation for nucleus. OLIG2 localizes to the nucleus as expected for a transcription factor. Reason: Correct annotation. Having both IBA and IEA evidence for nuclear localization is fine - they represent independent evidence sources confirming the same localization. Supporting Evidence: UniProtKB:Q13516 SUBCELLULAR LOCATION: Nucleus |
| GO:0005737 cytoplasm | IEA GO_REF:0000120 | ACCEPT | Summary: UniProt indicates OLIG2 is also found in the cytoplasm. The nuclear localization signal in the bHLH domain may be masked, allowing cytoplasmic localization until partner protein interaction triggers nuclear import. Reason: UniProt explicitly states cytoplasmic localization by similarity evidence. The annotation notes that the NLS may be masked in the native form, explaining dual nuclear/cytoplasmic distribution. Supporting Evidence: UniProtKB:Q13516 Cytoplasm {ECO:0000250} UniProtKB:Q13516 The NLS contained in the bHLH domain could be masked in the native form and translocation to the nucleus could be mediated by interaction either with class E bHLH partner protein or with NKX2-2 |
| GO:0006355 regulation of DNA-templated transcription | IEA GO_REF:0000002 | ACCEPT | Summary: OLIG2 is a transcription factor that regulates gene expression. This general biological process term accurately describes its function. Reason: Correct general term for OLIG2's role as a transcriptional regulator. While more specific terms for positive regulation are also present, this broader term appropriately captures the general function. Supporting Evidence: UniProtKB:Q13516 Transcription; Transcription regulation |
| GO:0021778 oligodendrocyte cell fate specification | IEA GO_REF:0000002 | ACCEPT | Summary: OLIG2 is essential for oligodendrocyte cell fate specification. This is a core function. Note on specification vs commitment distinction: "Specification" is the appropriate term because early OLIG2+ cells in the pMN domain can give rise to EITHER motor neurons OR oligodendrocytes depending on developmental timing and signals - the fate is reversible and context-dependent, which is the definition of specification per Slack (2011). Reason: This is a core function of OLIG2. UniProt explicitly states OLIG2 is "Required for oligodendrocyte and motor neuron specification." The protein establishes the pMN domain which gives rise to both motor neurons (early) and oligodendrocytes (later). The term "specification" (not "commitment") is appropriate because OLIG2+ cells retain plasticity to become either cell type depending on developmental context. Supporting Evidence: UniProtKB:Q13516 Required for oligodendrocyte and motor neuron specification in the spinal cord file:human/OLIG2/OLIG2-deep-research-falcon.md OLIG2 orchestrates neuron-glia fate decisions and is required for OPC specification and oligodendrocyte differentiation |
| GO:0030182 neuron differentiation | IEA GO_REF:0000002 | MODIFY | Summary: OLIG2 promotes motor neuron differentiation in the spinal cord and hindbrain. This general term is appropriate but more specific terms exist. Reason: While technically correct, OLIG2 specifically promotes motor neuron differentiation, not general neuron differentiation. In fact, OLIG2 antagonizes V2 and V3 interneuron fates. A more specific term would better capture OLIG2's function. Proposed replacements: spinal cord motor neuron differentiation Supporting Evidence: UniProtKB:Q13516 Required for oligodendrocyte and motor neuron specification in the spinal cord, as well as for the development of somatic motor neurons in the hindbrain UniProtKB:Q13516 Antagonist of V2 interneuron and of NKX2-2-induced V3 interneuron development |
| GO:0042552 myelination | IEA GO_REF:0000002 | KEEP AS NON CORE | Summary: OLIG2 promotes oligodendrocyte differentiation, and oligodendrocytes are responsible for myelination in the CNS. However, OLIG2 itself does not directly participate in the myelination process. Reason: Myelination is an indirect downstream effect of OLIG2's role in oligodendrocyte specification. OLIG2 specifies oligodendrocyte fate; the resulting oligodendrocytes then myelinate axons. OLIG2 is not expressed in mature myelinating oligodendrocytes and does not directly regulate myelin genes. This is a secondary phenotypic consequence rather than a direct function. Supporting Evidence: UniProtKB:Q13516 Required for oligodendrocyte and motor neuron specification |
| GO:0046983 protein dimerization activity | IEA GO_REF:0000002 | ACCEPT | Summary: bHLH transcription factors function as dimers. OLIG2's bHLH domain mediates homo- and heterodimerization with other bHLH proteins. Reason: Protein dimerization is essential for bHLH transcription factor function. OLIG2 interacts with NKX2-2 and ZNF488 through its bHLH domain. This is a core molecular function required for DNA binding and transcriptional activity. Supporting Evidence: UniProtKB:Q13516 The bHLH is essential for interaction with NKX2-2 UniProtKB:Q13516 Interacts with NKX2-2. Interacts with ZNF488 |
| GO:0048709 oligodendrocyte differentiation | IEA GO_REF:0000002 | ACCEPT | Summary: OLIG2 is required for oligodendrocyte differentiation. This is a core biological process function of the protein. Reason: Oligodendrocyte differentiation is one of the primary functions of OLIG2. UniProt states it "Functions together with ZNF488 to promote oligodendrocyte differentiation." This IEA annotation accurately captures a core function. Supporting Evidence: UniProtKB:Q13516 Functions together with ZNF488 to promote oligodendrocyte differentiation |
| GO:1990837 sequence-specific double-stranded DNA binding | IEA GO_REF:0000117 | ACCEPT | Summary: OLIG2 binds specific DNA sequences (E-boxes) through its bHLH domain. This annotation from ARBA machine learning is appropriate. Reason: OLIG2's bHLH domain binds E-box sequences specifically. This is a valid molecular function annotation that is also supported by IDA evidence (PMID:28473536). Supporting Evidence: UniProtKB:Q13516 Class B basic helix-loop-helix protein 1 |
| GO:0005515 protein binding | IPI PMID:32296183 A reference map of the human binary protein interactome. | REMOVE | Summary: The HuRI study (PMID:32296183) identified protein-protein interactions for OLIG2 using yeast two-hybrid screens. However, GO:0005515 "protein binding" is an uninformative term that should be avoided. Reason: "Protein binding" (GO:0005515) is too general to be informative. The HuRI paper is a large-scale interactome study that does not characterize specific functional interactions of OLIG2. Per curation guidelines, this term should be replaced with more specific binding terms. OLIG2's known specific interactions (with NKX2-2, ZNF488, class E bHLH proteins) are functionally relevant but this generic annotation does not capture them appropriately. Supporting Evidence: PMID:32296183 we present a human 'all-by-all' reference interactome map of human binary protein interactions, or 'HuRI' |
| GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific | IEA GO_REF:0000107 | ACCEPT | Summary: Duplicate of the IBA annotation. OLIG2 is an RNA Pol II-specific transcription factor. Reason: This IEA from Ensembl Compara ortholog transfer is consistent with the IBA annotation. Having multiple evidence types supporting the same annotation increases confidence. Supporting Evidence: UniProtKB:Q13516 Transcription; Transcription regulation |
| GO:0042802 identical protein binding | IEA GO_REF:0000107 | ACCEPT | Summary: bHLH proteins can form homodimers as well as heterodimers. OLIG2 likely homodimerizes through its bHLH domain. Reason: Homodimerization is a common property of bHLH transcription factors. While OLIG2's heterodimeric interactions are better characterized (with NKX2-2, ZNF488, class E bHLH partners), homodimerization is plausible and consistent with the protein family. Supporting Evidence: UniProtKB:Q13516 Class B basic helix-loop-helix protein 1 |
| GO:0071837 HMG box domain binding | IEA GO_REF:0000107 | UNDECIDED | Summary: OLIG2 interacts with NKX2-2, which contains a homeodomain. However, NKX2-2 does not contain an HMG box domain. This annotation may be an error in ortholog transfer. Reason: The annotation source is Ensembl Compara ortholog transfer. NKX2-2, a known OLIG2 partner, has a homeodomain but not an HMG box. SOX proteins have HMG boxes and interact with bHLH factors in neural development, but specific OLIG2-HMG box protein interactions are not well documented. Unable to verify this annotation without additional evidence. Supporting Evidence: UniProtKB:Q13516 Interacts with NKX2-2. Interacts with ZNF488 |
| GO:1990837 sequence-specific double-stranded DNA binding | IDA PMID:28473536 Impact of cytosine methylation on DNA binding specificities ... | ACCEPT | Summary: The Taipale lab SELEX study systematically characterized DNA binding specificities of human transcription factors. OLIG2 was among the 542 TFs analyzed. Reason: This IDA annotation is based on direct experimental evidence from methylation-sensitive SELEX analysis. The study provides systematic characterization of transcription factor DNA binding specificities. This is a core molecular function of OLIG2. Supporting Evidence: PMID:28473536 By analysis of 542 human TFs with methylation-sensitive SELEX (systematic evolution of ligands by exponential enrichment) |
| GO:0000785 chromatin | ISA GO_REF:0000113 | ACCEPT | Summary: Transcription factors bind to chromatin to regulate gene expression. OLIG2 is expected to associate with chromatin as part of its function. Reason: As a DNA-binding transcription factor, OLIG2 functions on chromatin. The ISA annotation from TFClass database is appropriate for a sequence- specific transcription factor. Supporting Evidence: UniProtKB:Q13516 Chromosomal rearrangement; Cytoplasm; Developmental protein; DNA-binding |
| GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific | ISA GO_REF:0000113 | ACCEPT | Summary: Third annotation for the same term from TFClass database. OLIG2 is classified as a sequence-specific DNA binding transcription factor. Reason: This ISA annotation from TFClass provides additional evidence for OLIG2's function as an RNA Pol II-specific transcription factor. Multiple evidence types converge on this core function. Supporting Evidence: UniProtKB:Q13516 Transcription; Transcription regulation |
Loading supporting content…
Download this section (compressed HTML)Q: What are the specific gene targets of OLIG2 in oligodendrocyte vs motor neuron specification programs?
Q: How does OLIG2 switch from promoting motor neuron to oligodendrocyte fate at different developmental stages?
Q: What is the role of OLIG2 phosphorylation and other post-translational modifications in regulating its activity?
Q: Does OLIG2's recruitment of BRG1/SMARCA4 to oligodendrocyte enhancers warrant a regulation-of-chromatin-organization term, or should GO reserve chromatin remodeling terms for the SWI/SNF ATPase that performs the step?
Experiment: ChIP-seq in neural progenitor cells to identify direct OLIG2 target genes and binding motifs in a mammalian cellular context.
Hypothesis: OLIG2 binds E-box sequences in promoters of oligodendrocyte and motor neuron specification genes
Type: ChIP-seq
Experiment: Time-course RNA-seq of OLIG2 knockout vs wild-type neural progenitors to identify genes regulated during motor neuron and oligodendrocyte differentiation.
Hypothesis: OLIG2 activates motor neuron and oligodendrocyte specification genes while repressing alternative neural fates
Type: RNA-seq
Experiment: Mass spectrometry-based identification of OLIG2 interaction partners in neural progenitor cells to characterize cell type-specific complexes.
Hypothesis: OLIG2 forms distinct transcriptional complexes during motor neuron vs oligodendrocyte specification
Type: IP-MS
Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)